SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-037151
Filing Date
2023-02-14
Accepted
2023-02-14 07:18:56
Documents
17
Period of Report
2023-02-13
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d289637d8k.htm   iXBRL 8-K 36269
2 EX-4.1 d289637dex41.htm EX-4.1 76800
3 EX-5.1 d289637dex51.htm EX-5.1 8680
4 EX-10.1 d289637dex101.htm EX-10.1 165730
5 EX-99.1 d289637dex991.htm EX-99.1 15895
9 GRAPHIC g289637g0214014358502.jpg GRAPHIC 4001
  Complete submission text file 0001193125-23-037151.txt   511434

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA iron-20230213.xsd EX-101.SCH 2877
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE iron-20230213_lab.xml EX-101.LAB 18737
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE iron-20230213_pre.xml EX-101.PRE 11725
11 EXTRACTED XBRL INSTANCE DOCUMENT d289637d8k_htm.xml XML 3466
Mailing Address 300 ONE KENDALL SQUARE, 3RD FLOOR CAMBRIDGE MA 02139
Business Address 300 ONE KENDALL SQUARE, 3RD FLOOR CAMBRIDGE MA 02139 (617) 401-4400
Disc Medicine, Inc. (Filer) CIK: 0001816736 (see all company filings)

IRS No.: 851613057 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39438 | Film No.: 23622347
SIC: 2834 Pharmaceutical Preparations